http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5817650-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 1997-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6f8db63b3780fc3338795eb2edb561b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02df9b12cd84718d0c715b2fbe2a16df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9f1c7b21f83f2fc5290076dd2b0aaff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87e27eaaf2908a208316a6bf547089ab
publicationDate 1998-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5817650-A
titleOfInvention Treatment of systemic lupus erythematosus with dehydroepiandrosterone
abstract Systemic lupus erythematosus (SLE) is treated with dehydroepiandrosterone or its metabolite, sulfate ester, by itself or in combination with other therapies. Substantial improvement in SLE patients is observed during the course of treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6552010-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2233141-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7396827-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0135975-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6854468-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0135975-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008169201-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004043973-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6605591-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7612034-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005113301-A1
priorityDate 1992-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5001119-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5567696-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4628052-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129756062
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136255554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127867644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395512

Total number of triples: 55.